Why doesn't Typology use oxybenzone?

However, controversies have arisen around this ingredient. It raises two main concerns, aside from allergic reactions: the fear that it may be an endocrine disruptor, and that it could be harmful to marine life and coral reefs, even though numerous scientific groups and regulatory bodies, including the FDA and CIR, have reviewed benzophenone-3 and asserted that it is safe for human health when used as an ingredient in sunscreens at the mandated concentration.

These controversies stem from concerns that have been raised about the relative ease with which oxybenzone is absorbed by the skin and into the bloodstream, to the order of 1 to 2%, following topical application. Similarly, traces of oxybenzone have been found in urine samples with a quantity varying between 0.4% and 2%. But does finding a measurable amount of BP-3 in the urine mean that the levels of BP-3 have a detrimental effect on health? In the face of such findings, countless research studies on the potential dangers of benzophenone-3 have emerged.

After being applied topically, this compound is absorbed by the skin, metabolised and/or excreted. According to a study based on oral and cutaneous administration of oxybenzone to laboratory rats, followed by blood, urine, faecal matter, and tissue sample analyses, this product is transformed within the body into three distinct metabolites: 2,4-dihydroxybenzophenone (DHB), 2,2-dihydroxy-4-methoxybenzophenone (DHMB), and 2,3,4-trihydroxybenzophenone (THB).

Oxybenzone declared as a contact allergen.

Benzophenone-3 has been linked to allergic contact dermatitis and photocontact dermatitis. Indeed, products containing oxybenzone can cause redness, swelling, itching, and fluid-filled blisters. In severe cases, anaphylaxis can occur. In a study involving 82 patients suffering from photodermatitis, more than a quarter showed a photoallergic reaction to oxybenzone.

Oxybenzone regarded as ecotoxic.

BP-3 also has an unfavourable environmental profile. It is considered an environmental contaminant and is suspected of being a threat to coral reefs, being linked to bleaching phenomena and massive coral mortality. Apparently, numerous cases of coral bleaching have been recorded following the presence of sunscreen residues in the sea. Due to these constraints, some states such as Hawaii and the Palau Islands have reacted and banned the use of sunscreens containing benzophenone-3. However, this ban is somewhat controversial and criticised by many scientific experts. The various studies have been conducted with very high concentrations, higher than those found in the environment, or direct application, either on isolated coral samples.

Similarly, other factors need to be considered: the actual amount of sunscreen applied, the vastness of the ocean, and marine currents. The most severe threats to the marine ecosystem are, for example, climate change with an increase in water temperature. Several researchers thus state that the damage caused by sunscreens to corals is negligible. The available studies on the impact of oxybenzone on coral decline are limited and non-repetitive. Benzophenone-3 would also harm the growth and ongoing photosynthetic processes of green algae, and its presence could also threaten the health of aquatic fauna.

Oxybenzone, an endocrine disruptor?

Recent studies have reported oestrogenic-like activity in vitro on cells and in vivo on rats/zebrafish of BP-3. Apparently, it would have an acute effect on endogenous reproductive hormone levels in humans and would interfere with the functioning of the endocrine system (hypothalamic-pituitary-gonadal axis), thus potentially affecting human health, following topical application.

This potential biological effect was first published in a study by LICHTENSTEIGER W. & co., where they demonstrated a 23% increase in the size of the uterus in immature rats following oral administration of oxybenzone. Subsequent studies were conducted to determine the equivalent amount of BP-3 to be used topically in humans to achieve the cumulative amount of oxybenzone orally administered to immature rats and reproduce the observed systemic oestrogenic effect.

However, while some studies have concluded that BP-3 has potential hormone-disrupting power, others have observed no biologically significant effect on hormone levels, indicating that the amount of BP-3 absorbed is not capable of disrupting the homeostasis of endogenous reproductive hormones in humans, even with the application of a formulation containing 10% oxybenzone.

Indeed, the minor differences observed in the levels of testosterone, estradiol, and inhibin B do not appear to be linked to exposure to benzophenone-3. Faced with such contradictory results, the current data are not sufficiently legitimate to extrapolate to humans, and oxybenzone must be the subject of more in-depth studies.

Note : A study has revealed that plasma concentrations of BP-3, 24 and 96 hours after the first application of a sunscreen formula, were not significantly different, neither in men nor in women, indicating that there is no accumulation, even after several days of topical application.

Oxybenzone, an aggravating factor or a promoter of cancer development?

Recently, studies have highlighted the potentiating effects of BP-3 exposure in cancer progression. A 2008 report revealed that exposing human lung cancer cells to non-toxic concentrations of oxybenzone could induce a behavioural change in the cells towards mesenchymal phenotypes (epithelial-mesenchymal transition). This is a process that facilitates the formation of metastases, namely the ability of anoikis-resistant tumour cells to migrate and invade surrounding tissues to form secondary tumours.

Other studies have reportedly identified effects of BP-3 on mammary tumorigenesis in female mice. In other words, oxybenzone would cause an increased proliferation of tumour cells and a reduced apoptosis of tumour cells through alterations in the immune cell populations of the tumour microenvironment. In conclusion, BP-3 would have the ability to potentiate the "aggressive" behaviours of cancer cells. However, further research is needed to confirm this effect of benzophenone-3 in humans.

What are the conclusions?

The CSSC has concluded that the use of oxybenzone as a UV filter at concentrations up to 6% in sun protection products does not pose a health risk, except as a potential contact allergen. Further investigations are necessary to assess the effects of BP-3 exposure on human health and the environment, in order to have conclusive evidence.

What we do know is that benzophenone-3 provides good sun protection, and helps to prevent skin cancers, skin lesions, as well as the risks of sunburn. However, in light of these results, which are somewhat inconclusive, we prefer to err on the side of caution and have decided to exclude it from the formulation of our sunscreen products as a precautionary principle, while further studies are being conducted.